Optomed

With European Investment Fund’s support, Optomed has been able to develop software solutions alongside handheld devices, offering AI solutions to read and analyse the data.

The Optomed Aurora handheld fundus camera combines high-quality imaging with ease of use for screening eye diseases like diabetic retinopathy, AMD, and glaucoma.

Optomed Aurora AEYE - on-the-spot detection of diabetic retinopathy with Artificial Intelligence. Screen and detect anywhere.

The Optomed Aurora IQ handheld fundus camera integrates AI for cost-effective eye screenings.

Optomed offers career opportunities in medical technology.

Commit is a groundbreaking software company that provides an exciting working environment to a variety of professionals.

Optomed employs professionals with diverse backgrounds; employee stories are available.

I have a passion for science and medical technology. I have worked in medical technology and healthcare for 30 years in various roles and functions, both in Finland and abroad, leading and managing operations worldwide.

Founded in 2004, Optomed offers handheld fundus cameras for accessible eye screening worldwide.

Optomed develops handheld fundus cameras and software for managing, screening, and diagnosing diabetes-related eye diseases.

Optomed Plc is a Finnish health care technology company and one of the leading providers of handheld fundus cameras and eye-screening solutions.

Optomed’s handheld fundus camera includes optional AI for retinal imaging and screening; it is non-mydriatic and clinically validated.

Optomed manufactures handheld fundus cameras globally to enable eye screening in any location.

Optomed Plc publishes its interim financial report covering the first nine months of 2026. The company provides updates on its ophthalmic device business and operational performance for investors and stakeholders.

Nov 2026Optomed PlcNews article

Optomed Plc’s Board of Directors approves a new stock option plan to incentivize employees and key stakeholders. The move aims to align interests with the company’s growth strategy, though specifics of the plan remain undisclosed.

Sep 2026Optomed PlcNews article

Optomed Plc earns the EcoVadis Committed Badge, recognizing its sustainability efforts. The company demonstrates a commitment to environmental and social responsibility through its operations. This achievement highlights Optomed’s focus on sustainable practices in the medical technology sector.

Sep 2026Optomed PlcNews article

Optomed Plc secures a significant order from an unspecified customer in the United States. The company, specializing in ophthalmic medical devices, expands its market presence beyond its European operations. No further details on the order value or product specifics are disclosed in the release.

Jun 2026Optomed PlcNews article